SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tech Master who wrote (521)5/4/1998 3:00:00 PM
From: zebraspot  Read Replies (1) of 2135
 
That's not exactly what he said.

Regardless of that spin, don't you agree that if these drugs prove out on humans, and NIH has it as its top priority, and Clinton on down get excited about how it can not only cure cancer but cure the national debt and balance the budget via Medicare/Medicaid/SS savings, this thing will be on the fastest track through FDA that anyone has ever seen?

Focusing on $5 or $10 price moves, today and this week, misses the whole point of this stock. Some of you probably traded MSFT the first week of its IPO and made a couple of grand and we're happy as a lark for about a week and a half.

Long term risk/reward looks pretty outstanding here. The current market cap is less than $700 million. If they cure cancer, what do you think that market cap may go to?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News